Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M114Revenue $M11.3Net Margin (%)-183.1Altman Z-Score-8.5
Enterprise Value $M60.2EPS $-0.4Operating Margin %-191.7Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.4Pre-tax Margin (%)-183.1Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %-12.8Quick Ratio3.3Cash flow > EarningsN
Price/Sales10.05-y EBITDA Growth Rate %-14.3Current Ratio3.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-29.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-46.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M62.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARQL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARQLFirst Eagle Investment 2015-03-31 Add0.01%$1.1 - $2.46
($1.59)
$ 1.8114%Add 28.69%5,719,968
ARQLFirst Eagle Investment 2014-12-31 Add$1.06 - $1.36
($1.18)
$ 1.8153%Add 56.31%4,444,899
ARQLGeorge Soros 2014-09-30 Sold Out $1.12 - $1.56
($1.31)
$ 1.8138%Sold Out0
ARQLGeorge Soros 2014-06-30 Buy $1.34 - $2.04
($1.56)
$ 1.8116%New holding78,600
ARQLFirst Eagle Investment 2013-09-30 Reduce-0.01%$2.15 - $2.79
($2.51)
$ 1.81-28%Reduce 26.47%3,314,553
ARQLFirst Eagle Investment 2012-12-31 Add0.01%$2.18 - $2.95
($2.6)
$ 1.81-30%Add 49.46%4,539,651
ARQLFirst Eagle Investment 2012-06-30 Add0.01%$5.53 - $8.16
($6.56)
$ 1.81-72%Add 28.79%2,673,589
ARQLGeorge Soros 2011-12-31 Sold Out -0.0014%$4.58 - $6.05
($5.55)
$ 1.81-67%Sold Out0
ARQLGeorge Soros 2011-09-30 Add$4.11 - $6.64
($5.2)
$ 1.81-65%Add 54.79%16,100
ARQLFirst Eagle Investment 2011-03-31 Add0.03%$5.85 - $6.95
($6.41)
$ 1.81-72%Add 84.22%1,693,456
ARQLGeorge Soros 2011-03-31 Buy $5.85 - $6.95
($6.41)
$ 1.81-72%New holding12,200
ARQLFirst Eagle Investment 2010-12-31 Add0.01%$4.95 - $6.14
($5.53)
$ 1.81-67%Add 29.43%919,266
ARQLFirst Eagle Investment 2010-03-31 Reduce-0.02%$3.04 - $3.92
($3.45)
$ 1.81-48%Reduce 56.47%685,266
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARQL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ARQL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ZENNER PATRICK JDirector 2015-03-11Buy10,625$2.32-21.98view
Pucci PaoloCEO 2014-11-20Buy5,000$1.2643.65view
ZENNER PATRICK JDirector 2014-11-14Buy20,830$1.250.83view
Messenger William GDirector 2014-11-14Buy8,500$1.2149.59view
Kelley Susan L.Director 2014-11-13Buy50,000$1.250.83view
Pucci PaoloCEO 2014-09-04Buy5,000$1.3138.17view
Pucci PaoloCEO 2014-05-23Buy5,000$1.429.29view
Pucci PaoloCEO 2014-05-20Buy5,000$1.4227.46view
ZENNER PATRICK JDirector 2014-03-17Buy4,715$2.12-14.62view
Pucci PaoloCEO 2014-03-13Buy10,000$2.1-13.81view

Press Releases about ARQL :

    Quarterly/Annual Reports about ARQL:

    News about ARQL:

    Articles On GuruFocus.com
    Jean-Marie Eveillard Increases Stakes in Cancer Therapeutics Company Arqule Inc May 05 2015 
    Jean-Marie Eveillard Adds to Stake in Arqule Inc. May 03 2015 
    comment on ARQL Nov 29 2012 
    ArQule Inc. Reports Operating Results (10-Q) Nov 09 2010 
    ArQule Inc. Reports Operating Results (10-Q) Aug 04 2010 
    ArQule Inc. Reports Operating Results (10-Q) May 06 2010 
    cooldecency99 note on ARQL May 01 2010 
    ArQule Inc. (ARQL) CEO Paolo Pucci buys 5,000 Shares Nov 13 2009 
    ArQule Inc. Reports Operating Results (10-Q) Aug 07 2009 
    ArQule Reports Second Quarter 2009 Financial Results Aug 06 2009 

    More From Other Websites
    ArQule, Inc. to Present at Jefferies 2015 Global Healthcare Conference May 27 2015
    ArQule, Inc. to Present at Jefferies 2015 Global Healthcare Conference May 27 2015
    ARQULE INC Financials May 15 2015
    ARQULE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 13 2015
    10-Q for ArQule, Inc. May 08 2015
    ARQULE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... May 07 2015
    ARQULE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 06 2015
    ArQule Reports First Quarter 2015 Financial Results May 06 2015
    ArQule reports 1Q loss May 06 2015
    ArQule reports 1Q loss May 06 2015
    Q1 2015 ArQule Inc Earnings Release - 07:00 am ET May 06 2015
    ArQule Reports First Quarter 2015 Financial Results May 06 2015
    ArQule and Beryllium Announce Collaborative Research and Development Agreement May 05 2015
    ArQule and Beryllium Announce Collaborative Research and Development Agreement May 05 2015
    3 Biotech Stocks With Big Phase 3 Catalyst Data Due in 2015 May 01 2015
    ArQule to Report First Quarter 2015 Financial Results on May 6, 2015 Apr 29 2015
    ArQule to Report First Quarter 2015 Financial Results on May 6, 2015 Apr 29 2015
    La Jolla Pharmaceutical (LJPC) in Focus: Stock Up 14.4% - Tale of the Tape Apr 22 2015
    Zacks Rank #1 Additions for Tuesday - Tale of the Tape Apr 21 2015
    ArQule Announces Data Presentations with ARQ 087, Inhibitor of FGFR, at AACR Apr 21 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK